{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:56:02Z","timestamp":1784789762783,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of the Health Commission of Anhui Province","award":["AHWJ2024Aa30476, AHWJ2024BAh30020"],"award-info":[{"award-number":["AHWJ2024Aa30476, AHWJ2024BAh30020"]}]},{"name":"Scientific Research Project of Anhui Provincial Education Department","award":["2022AH040184, 2024AH010035"],"award-info":[{"award-number":["2022AH040184, 2024AH010035"]}]},{"name":"Anhui University Research Plan","award":["2023AH053392"],"award-info":[{"award-number":["2023AH053392"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFB3814600"],"award-info":[{"award-number":["2024YFB3814600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["52131305, 52203196, 52273308"],"award-info":[{"award-number":["52131305, 52203196, 52273308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03418-7","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:46:21Z","timestamp":1747734381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting phosphatidylserine in tumor cell membranes with a zinc-containing molecule to efficiently combat tumor metastasis"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiao-Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Zong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Huan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Zi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"3418_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Daron M, Morel Y, Medzhitov R, Vivier E. Harnessing innate immunity in cancer therapy. Nature. 2019;574:45\u201356.","journal-title":"Nature"},{"key":"3418_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"3418_CR3","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.","journal-title":"Nat Commun"},{"key":"3418_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrc.2017.83","volume":"17","author":"MJ Mitchell","year":"2017","unstructured":"Mitchell MJ, Jain RK, Langer R. Engineering and physical sciences in oncology: challenges and opportunities. Nat Rev Cancer. 2017;17:659\u201375.","journal-title":"Nat Rev Cancer"},{"key":"3418_CR5","first-page":"100","volume":"71","author":"JH Grosset","year":"2000","unstructured":"Grosset JH. The new challenges for chemotherapy research. Lepr Rev. 2000;71:100\u20134.","journal-title":"Lepr Rev"},{"key":"3418_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583\u201392.","journal-title":"Nat Rev Cancer"},{"key":"3418_CR7","first-page":"878","volume":"8","author":"IF Tannock","year":"2002","unstructured":"Tannock IF, Lee C, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res. 2002;8:878\u201384.","journal-title":"Clin Cancer Res"},{"key":"3418_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41588-020-0590-9","volume":"52","author":"KH Lin","year":"2020","unstructured":"Lin KH, Rutter J, Xie A, Pardieu B, Winn ET, Dal Bello R, et al. Using antagonistic Pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer. Nat Genet. 2020;52:408\u201317.","journal-title":"Nat Genet"},{"key":"3418_CR9","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1002\/anie.201403036","volume":"53","author":"T Sun","year":"2014","unstructured":"Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in Cancer therapy. Angew Chem Int Ed. 2014;53:12320\u201364.","journal-title":"Angew Chem Int Ed"},{"key":"3418_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nmat3792","volume":"12","author":"VP Chauhan","year":"2013","unstructured":"Chauhan VP, Jain RK. Strategies for advancing cancer nanomedicine. Nat Mater. 2013;12:958\u201362.","journal-title":"Nat Mater"},{"key":"3418_CR11","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/natrevmats.2016.69","volume":"1","author":"T Lammers","year":"2016","unstructured":"Lammers T, Kiessling F, Ashford M, Hennink WE, Crommelin DJA, Storm G. Cancer nanomedicine: is targeting our target? Nat Rev Mater. 2016;1:16069.","journal-title":"Nat Rev Mater"},{"key":"3418_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc A, Maier M, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019;14:1084\u201387.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR13","first-page":"553","volume":"55","author":"Y-S Liao","year":"2024","unstructured":"Liao Y-S, Liang J-X, Wen Z, Cai M-Z, Song Z-Z, Zhang N-Y, et al. Strategies and applications of cell membrane surface functionalization of polymer materials. Acta Polym Sin. 2024;55:553\u201372.","journal-title":"Acta Polym Sin"},{"key":"3418_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941\u201351.","journal-title":"Nat Biotechnol"},{"key":"3418_CR15","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","volume":"66","author":"H Hillaireau","year":"2009","unstructured":"Hillaireau H, Couvreur P. Nanocarriers\u2019 entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009;66:2873\u201396.","journal-title":"Cell Mol Life Sci"},{"key":"3418_CR16","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1021\/acs.chemrev.7b00678","volume":"118","author":"MP Stewart","year":"2018","unstructured":"Stewart MP, Langer R, Jensen KF. Intracellular delivery by membrane disruption: mechanisms, strategies, and concepts. Chem Rev. 2018;118:7409\u2013531.","journal-title":"Chem Rev"},{"key":"3418_CR17","first-page":"11254","volume":"146","author":"N Shao","year":"2024","unstructured":"Shao N, Yuan L, Liu L, Cong Z, Wang J, Wu Y, Liu R. Reversing anticancer drug resistance by synergistic combination of chemotherapeutics and membranolytic antitumor \u03b2-peptide polymer. J Am Chem Soc. 2024;146:11254\u201365.","journal-title":"J Am Chem Soc"},{"key":"3418_CR18","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1021\/jacs.2c00452","volume":"144","author":"N Shao","year":"2022","unstructured":"Shao N, Yuan L, Ma P, Zhou M, Xiao X, Cong Z, et al. Heterochiral \u03b2-peptide polymers combating multidrug-resistant cancers effectively without inducing drug resistance. J Am Chem Soc. 2022;144:7283\u201394.","journal-title":"J Am Chem Soc"},{"key":"3418_CR19","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/jacs.7b11468","volume":"140","author":"NH Park","year":"2018","unstructured":"Park NH, Cheng W, Lai F, Yang C, Florez de Sessions P, Periaswamy B, et al. Addressing drug resistance in cancer with macromolecular chemotherapeutic agents. J Am Chem Soc. 2018;140:4244\u201352.","journal-title":"J Am Chem Soc"},{"key":"3418_CR20","doi-asserted-by":"publisher","first-page":"2001108","DOI":"10.1002\/adma.202001108","volume":"32","author":"W Shen","year":"2020","unstructured":"Shen W, Zhang Y, Wan P, An L, Zhang P, Xiao C, Chen X. Antineoplastic Drug-Free anticancer strategy enabled by Host\u2010Defense\u2010Peptides\u2010Mimicking synthetic polypeptides. Adv Mater. 2020;32:2001108.","journal-title":"Adv Mater"},{"key":"3418_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41565-022-01085-5","volume":"17","author":"M Liu","year":"2022","unstructured":"Liu M, Huang L, Zhang W, Wang X, Geng Y, Zhang Y, et al. A transistor-like pH-sensitive nanodetergent for selective cancer therapy. Nat Nanotechnol. 2022;17:541\u201351.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/jacs.4c14199","volume":"147","author":"J Wang","year":"2024","unstructured":"Wang J, Yuan Y, Su C, Bao Y, Xu W, Yao Y, et al. pH-Ultrasensitive membranolytic polyesters with alternating sequence of ionizable and hydrophobic groups for selective oncolytic therapy. J Am Chem Soc. 2024;147:1008\u201316.","journal-title":"J Am Chem Soc"},{"key":"3418_CR23","doi-asserted-by":"publisher","first-page":"12824","DOI":"10.1021\/acsami.0c16576","volume":"13","author":"F Fan","year":"2021","unstructured":"Fan F, Jin L, Yang L. pH-sensitive nanoparticles composed solely of membrane-disruptive macromolecules for treating pancreatic cancer. ACS Appl Mater Interfaces. 2021;13:12824\u201335.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3418_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2017.08.012","volume":"52","author":"B Sharma","year":"2018","unstructured":"Sharma B, Kanwar SS, Phosphatidylserine. A cancer cell targeting biomarker. Semin Cancer Biol. 2018;52:17\u201325.","journal-title":"Semin Cancer Biol"},{"key":"3418_CR25","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2016.11","volume":"23","author":"R Birge","year":"2016","unstructured":"Birge R, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 2016;23:962\u201378.","journal-title":"Cell Death Differ"},{"key":"3418_CR26","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.bbamem.2011.07.026","volume":"1808","author":"S Riedl","year":"2011","unstructured":"Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S, Novak A, et al. In search of a novel target\u2014Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. BBA-Biomembranes. 2011;1808:2638\u201345.","journal-title":"BBA-Biomembranes"},{"key":"3418_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","volume":"20","author":"D DeRyckere","year":"2023","unstructured":"DeRyckere D, Huelse JM, Earp HS, Graham DK. TAM family kinases as therapeutic targets at the interface of cancer and immunity. Nat Rev Clin Oncol. 2023;20:755\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"3418_CR28","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1039\/D2CS00757F","volume":"52","author":"K Peng","year":"2023","unstructured":"Peng K, Zheng Y, Xia W, Mao Z-W. Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses. Chem Soc Rev. 2023;52:2790\u2013832.","journal-title":"Chem Soc Rev"},{"key":"3418_CR29","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1002\/anie.201812489","volume":"58","author":"VE Zwicker","year":"2019","unstructured":"Zwicker VE, Oliveira BL, Yeo JH, Fraser ST, Bernardes GJ, New EJ, Jolliffe KA. A fluorogenic probe for cell surface phosphatidylserine using an intramolecular indicator displacement sensing mechanism. Angew Chem Int Ed. 2019;58:3087\u201391.","journal-title":"Angew Chem Int Ed"},{"key":"3418_CR30","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1021\/jacs.4c14394","volume":"147","author":"F Gao","year":"2025","unstructured":"Gao F, You W, Zhang L, Shen A-Z, Chen G, Zhang Z, et al. Copper chelate targeting externalized phosphatidylserine inhibits PD-L1 expression and enhances Cancer immunotherapy. J Am Chem Soc. 2025;147:5796\u2013807.","journal-title":"J Am Chem Soc"},{"key":"3418_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/med.21272","volume":"34","author":"VD Sharma","year":"2014","unstructured":"Sharma VD, Ilies MA. Heterocyclic cationic gemini surfactants: A comparative overview of their synthesis, self-assembling, physicochemical, and biological properties. Med Res Rev. 2014;34:1\u201344.","journal-title":"Med Res Rev"},{"key":"3418_CR32","doi-asserted-by":"publisher","first-page":"18294","DOI":"10.1021\/jacs.1c08898","volume":"143","author":"J Weng","year":"2021","unstructured":"Weng J, Wang Y, Zhang Y, Ye D. An activatable Near-Infrared fluorescence probe for in vivo imaging of acute kidney injury by targeting phosphatidylserine and Caspase-3. J Am Chem Soc. 2021;143:18294\u2013304.","journal-title":"J Am Chem Soc"},{"key":"3418_CR33","doi-asserted-by":"publisher","first-page":"155596","DOI":"10.1016\/j.cej.2024.155596","volume":"498","author":"Q Shao","year":"2024","unstructured":"Shao Q, Shen C-L, You W, Nie X, Huang W-Q, Gao F, et al. DPA-Zn enables targeting and bypassing endosomal trapping delivery of a genome-editing system into cancer cells via phosphatidylserine-mediated endocytic pathway. Chem Eng J. 2024;498:155596.","journal-title":"Chem Eng J"},{"key":"3418_CR34","doi-asserted-by":"publisher","first-page":"2203252","DOI":"10.1002\/adhm.202203252","volume":"12","author":"X Nie","year":"2023","unstructured":"Nie X, You W, Zhang Z, Gao F, Zhou XH, Wang HL, et al. DPA-Zinc around polyplexes acts like PEG to reduce protein binding while targeting Cancer cells. Adv Healthc Mater. 2023;12:2203252.","journal-title":"Adv Healthc Mater"},{"key":"3418_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1021\/prechem.3c00056","volume":"1","author":"A Umer","year":"2023","unstructured":"Umer A, Ghouri MD, Muyizere T, Aqib RM, Muhaymin A, Cai R, Chen C. Engineered Nano\u2013Bio interfaces for stem cell therapy. Precis Chem. 2023;1:341\u201356.","journal-title":"Precis Chem"},{"key":"3418_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41565-024-01826-8","volume":"20","author":"W-Q Huang","year":"2025","unstructured":"Huang W-Q, You W, Zhu Y-Q, Gao F, Wu Z-Z, Chen G, et al. Autophagosomes coated in situ with nanodots act as personalized cancer vaccines. Nat Nanotechnol. 2025;20:451\u201362.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR37","doi-asserted-by":"publisher","first-page":"2404199","DOI":"10.1002\/adma.202404199","volume":"36","author":"WQ Huang","year":"2024","unstructured":"Huang WQ, Zhu YQ, Gao F, You W, Chen G, Nie X, et al. Nanogalvanic cells release highly reactive electrons in tumors to effectively eliminate tumors. Adv Mater. 2024;36:2404199.","journal-title":"Adv Mater"},{"key":"3418_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","volume":"14","author":"RV Der Meel","year":"2019","unstructured":"Der Meel RV, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol. 2019;14:1007\u201317.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR39","first-page":"1317","volume":"37","author":"GL Lu","year":"2024","unstructured":"Lu GL, Jin YT, Liu XR, Huang CJ. Stimulus-responsive polymeric nanocarriers for platinum drug delivery. Polym Bull. 2024;37:1317\u201336.","journal-title":"Polym Bull"},{"key":"3418_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10118-022-2775-4","volume":"41","author":"M-X Zhou","year":"2023","unstructured":"Zhou M-X, Zhang J-Y, Cai X-M, Dou R, Ruan L-F, Yang W-J, et al. Tumor-penetrating and mitochondria-targeted drug delivery overcomes doxorubicin resistance in lung cancer. Chin J Polym Sci. 2023;41:525\u201337.","journal-title":"Chin J Polym Sci"},{"key":"3418_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nnano.2007.88","volume":"2","author":"N Nishiyama","year":"2007","unstructured":"Nishiyama N. Nanocarriers shape up for long life. Nat Nanotechnol. 2007;2:203\u201304.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffensnakken H, Reutelingsperger CPM. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39\u201351.","journal-title":"J Immunol Methods"},{"key":"3418_CR43","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","volume":"26","author":"S Arena","year":"2020","unstructured":"Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, et al. A subset of colorectal cancers with cross-sensitivity to Olaparib and oxaliplatin. Clin Cancer Res. 2020;26:1372\u201384.","journal-title":"Clin Cancer Res"},{"key":"3418_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Vanden Berghe T, Ravichandran KS, Vandenabeele P. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13:1\u201315.","journal-title":"Nat Commun"},{"key":"3418_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.plipres.2015.04.003","volume":"59","author":"PV Escrib\u00e1","year":"2015","unstructured":"Escrib\u00e1 PV, Busquets X, Inokuchi J, Balogh G, T\u00f6r\u00f6k Z, Horv\u00e1th I, et al. Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Prog Lipid Res. 2015;59:38\u201353.","journal-title":"Prog Lipid Res"},{"key":"3418_CR46","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.1021\/acs.analchem.8b02144","volume":"90","author":"A Kenaan","year":"2018","unstructured":"Kenaan A, Cheng J, Qi D, Chen D, Cui D, Song J. Physicochemical analysis of DPPC and photopolymerizable liposomal binary mixture for Spatiotemporal drug release. Anal Chem. 2018;90:9487\u201394.","journal-title":"Anal Chem"},{"key":"3418_CR47","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/s41589-020-00688-0","volume":"16","author":"M Doktorova","year":"2020","unstructured":"Doktorova M, Symons JL, Levental I. Structural and functional consequences of reversible lipid asymmetry in living membranes. Nat Chem Biol. 2020;16:1321\u201330.","journal-title":"Nat Chem Biol"},{"key":"3418_CR48","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/0008-5472.CAN-15-1970","volume":"76","author":"W Zhao","year":"2016","unstructured":"Zhao W, Prijic S, Urban BC, Tisza MJ, Zuo Y, Li L, et al. Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity. Cancer Res. 2016;76:2037\u201349.","journal-title":"Cancer Res"},{"key":"3418_CR49","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.healun.2020.01.1075","volume":"39","author":"A Sweedo","year":"2020","unstructured":"Sweedo A, Wise LM, Sheriff J, Bluestein D, Purdy JG, Slepian MJ. MCS hypershear modulates platelet membrane fluidity, lipid species, and is gender specific. J Heart Lung Transpl. 2020;39:S147.","journal-title":"J Heart Lung Transpl"},{"key":"3418_CR50","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1016\/j.bbamem.2016.07.013","volume":"1858","author":"AM do Canto","year":"2016","unstructured":"do Canto AM, Robalo JR, Santos PD, Carvalho AJP, Ramalho JP, Loura LM. Diphenylhexatriene membrane probes DPH and TMA-DPH: A comparative molecular dynamics simulation study. BBA-Biomembranes. 2016;1858:2647\u201361.","journal-title":"BBA-Biomembranes"},{"key":"3418_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","volume":"32","author":"AS Azmi","year":"2013","unstructured":"Azmi AS, Bao B, Sarkar FH. Exosomes in Cancer development, metastasis and drug resistance: A comprehensive review. Cancer Metastasis Rev. 2013;32:623\u201342.","journal-title":"Cancer Metastasis Rev"},{"key":"3418_CR52","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/jacs.7b11468","volume":"140","author":"NH Park","year":"2018","unstructured":"Park NH, Cheng W, Lai F, Yang C, De Sessions PF, Periaswamy B, et al. Addressing drug resistance in Cancer with macromolecular chemotherapeutic agents. J Am Chem Soc. 2018;140:4244\u201352.","journal-title":"J Am Chem Soc"},{"key":"3418_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575:299\u2013309.","journal-title":"Nature"},{"key":"3418_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrclinonc.2016.128","volume":"14","author":"OA Martin","year":"2017","unstructured":"Martin OA, Anderson RL, Narayan K, Macmanus M. Does the mobilization of Circulating tumour cells during cancer therapy cause metastasis? Nat Rev Clin Oncol. 2017;14:32\u201344.","journal-title":"Nat Rev Clin Oncol"},{"key":"3418_CR55","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41574-021-00514-0","volume":"17","author":"E Peverelli","year":"2021","unstructured":"Peverelli E, Treppiedi D, Mangili F, Catalano R, Spada A, Mantovani G. Drug resistance in pituitary tumours: from cell membrane to intracellular signalling. Nat Rev Endocrinol. 2021;17:560\u201371.","journal-title":"Nat Rev Endocrinol"},{"key":"3418_CR56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.devcel.2020.10.011","volume":"56","author":"V Gensbittel","year":"2021","unstructured":"Gensbittel V, Kr\u00e4ter M, Harlepp S, Busnelli I, Guck J, Goetz JG. Mechanical adaptability of tumor cells in metastasis. Dev Cell. 2021;56:164\u201379.","journal-title":"Dev Cell"},{"key":"3418_CR57","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","volume":"14","author":"R van der Meel","year":"2019","unstructured":"van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol. 2019;14:1007\u201317.","journal-title":"Nat Nanotechnol"},{"key":"3418_CR58","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ncb1279","volume":"7","author":"JI Elliott","year":"2005","unstructured":"Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C, et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol. 2005;7:808\u201316.","journal-title":"Nat Cell Biol"},{"key":"3418_CR59","doi-asserted-by":"publisher","first-page":"eabe2888","DOI":"10.1126\/sciadv.abe2888","volume":"7","author":"T Wan","year":"2021","unstructured":"Wan T, Pan Q, Ping Y. Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders. Sci Adv. 2021;7:eabe2888.","journal-title":"Sci Adv"},{"key":"3418_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1021\/prechem.3c00038","volume":"1","author":"Y Luo","year":"2023","unstructured":"Luo Y. Chemistry in the era of artificial intelligence. Precis Chem. 2023;1:127\u201328.","journal-title":"Precis Chem"},{"key":"3418_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/prechem.4c00086","volume":"3","author":"Z Li","year":"2024","unstructured":"Li Z. Artificial-Intelligence driven precision chemistry. Precis Chem. 2024;3:1\u20132.","journal-title":"Precis Chem"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03418-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03418-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03418-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:20:40Z","timestamp":1747736440000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03418-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03418-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Ethical Committee of the University of Science and Technology of China USTCACUC23030122089.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}